Disease economics – economic aspects of anti-bacterial and anti-microbial resistance: comparative analysis of Europe and other world regions

The role of public health, and for that matter even more a disease, is a comparatively lower and thus underestimated factor in economics and business. It is however recognized as an issue by economists and entrepreneurs themselves, but not enough by general public and partially insufficient by public health practitioners. This is not an accuse to any field as in the economic governance era of labour division, specialization and focusing on one`s designated speciality is a conventional paradigm. On the other hand, even though the specialization has taken widespread place, the interdisciplinarity and potential of inter-sectoral cooperation is widely increasing. As the economic system of societal governance is rather bio-logical then mechanic system, the production and thus success factors in economics and business, particularly labour, must, of course, be nurtured also from the perspective of bio-sector, namely medicine and health. Another aspect showing the increasing interactivity and interdependence between the medicine and business is the high increase of amount and easiness of availability of medicine for general consumer society, including those of antibiotics. The aim of the article is to show economic and other related non-medical aspects – their impact and consequences – of the anti-biotical and anti-microbial resistance. Keywords: Economics and Business, Health Economics, Public Health, ABR, AMR.